SCHEMBL9274348

SCHEMBL9274348

CCCCc1cn(C2CC2(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)nc1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 15/20 0.58
AGTR2 P50052 12/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9278465 0.94 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9273855 0.93 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9201439 0.93 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL9201382 0.92 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9206864 0.91 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9277783 0.90 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9278756 0.90 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL7675463 0.90 AGTR1 (0.63) AGTR1AGTR2
SCHEMBL9277161 0.89 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL7679989 0.89 AGTR1 (0.62) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0664803-A1 N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1995-08-02 EP disclosed
WO-1994008989-A1 N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1994-04-28 WO disclosed